TARGETING SYNOVIAL SARCOMA WITH CANCER TESTIS ANTIGEN INCORPORATED ONCOLYTIC VIRUSES

$795,001FY2021Defense Health AgencyDOD

Mayo Clinic, Rochester MN

Investigators

View source on USAspending →